AroCell Future Growth

Future criteria checks 2/6

AroCell is forecast to grow earnings and revenue by 25.6% and 25.9% per annum respectively while EPS is expected to grow by 5.4% per annum.

Key information

25.6%

Earnings growth rate

5.4%

EPS growth rate

Life Sciences earnings growth43.1%
Revenue growth rate25.9%
Future return on equityn/a
Analyst coverage

Low

Last updated26 Oct 2024

Recent future growth updates

Recent updates

Is Now The Time To Look At Buying AroCell AB (publ) (STO:AROC)?

Apr 20
Is Now The Time To Look At Buying AroCell AB (publ) (STO:AROC)?

Estimating The Intrinsic Value Of AroCell AB (publ) (STO:AROC)

Feb 27
Estimating The Intrinsic Value Of AroCell AB (publ) (STO:AROC)

At kr0.45, Is AroCell AB (publ) (STO:AROC) Worth Looking At Closely?

Nov 07
At kr0.45, Is AroCell AB (publ) (STO:AROC) Worth Looking At Closely?

We Think AroCell (STO:AROC) Can Afford To Drive Business Growth

Aug 10
We Think AroCell (STO:AROC) Can Afford To Drive Business Growth

AroCell (STO:AROC) Is In A Good Position To Deliver On Growth Plans

Apr 18
AroCell (STO:AROC) Is In A Good Position To Deliver On Growth Plans

We're Hopeful That AroCell (STO:AROC) Will Use Its Cash Wisely

Jan 03
We're Hopeful That AroCell (STO:AROC) Will Use Its Cash Wisely

Earnings and Revenue Growth Forecasts

OM:AROC - Analysts future estimates and past financials data (SEK Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202694N/AN/AN/A1
12/31/202574-35261
12/31/202458-42-5N/A1
9/30/202452-51-8-7N/A
6/30/202448-54-9-8N/A
3/31/202445-56-14-13N/A
12/31/202343-59-15-13N/A
9/30/202346-59-19-15N/A
6/30/202346-57-15-11N/A
3/31/202340-57-14-10N/A
12/31/202237-59-18-14N/A
9/30/202230-62-21-21N/A
6/30/202226-69-27-26N/A
3/31/202220-59-30-30N/A
12/31/202112-50-29-28N/A
9/30/20216-36-23-23N/A
6/30/20210-25-21-21N/A
3/31/20210-25-20-20N/A
12/31/20200-24-19-19N/A
9/30/20200-24-19-19N/A
6/30/20200-22-16-16N/A
3/31/20200-21-16-16N/A
12/31/20190-21-15-15N/A
9/30/20190-20-16-16N/A
6/30/20190-21-18-18N/A
3/31/20191-22-18-18N/A
12/31/20181-21-16-16N/A
9/30/20181-21-15-15N/A
6/30/20181-19N/A-14N/A
3/31/20180-17N/A-13N/A
12/31/20171-17N/A-15N/A
9/30/20170-13N/A-16N/A
6/30/20170-12N/A-13N/A
3/31/20170-11N/A-11N/A
12/31/20160-9N/A-7N/A
9/30/20161-9N/A-8N/A
6/30/20160-8N/A-8N/A
3/31/20160-8N/A-7N/A
12/31/20150-7N/A-9N/A
9/30/2015N/A-9N/AN/AN/A
6/30/2015N/A-8N/AN/AN/A
3/31/2015N/A-8N/AN/AN/A
12/31/2014N/A-6N/AN/AN/A
9/30/2014N/A-5N/AN/AN/A
6/30/2014N/A-5N/AN/AN/A
3/31/2014N/A-4N/AN/AN/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: AROC is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: AROC is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: AROC is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: AROC's revenue (25.9% per year) is forecast to grow faster than the Swedish market (1.3% per year).

High Growth Revenue: AROC's revenue (25.9% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if AROC's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 01:29
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

AroCell AB (publ) is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Oscar BergmanRedeye